Takashi Nakaike

Miyazaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

The effective and safe administration of Epcoritamab in relapsed CD19-CD5+ DLBCL following CAR-T therapy.

The effective and safe administration of Epcoritamab in relapsed CD19-CD5+ DLBCL following CAR-T therapy.

Journal: Blood cell therapy

Published: December 23, 2024

A case of successful CAR-T cell therapy for early isolated CNS recurrence of DLBCL with persistent CAR-T cells.

A case of successful CAR-T cell therapy for early isolated CNS recurrence of DLBCL with persistent CAR-T cells.

Journal: Blood cell therapy

Published: October 27, 2023

The clinical impact of the ratio of C-reactive protein to albumin (CAR) in patients with acute- and lymphoma-type adult T-cell leukemia-lymphoma (ATL).

The clinical impact of the ratio of C-reactive protein to albumin (CAR) in patients with acute- and lymphoma-type adult T-cell leukemia-lymphoma (ATL).

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: June 28, 2023

Secondary Skin Cancer in a Case with Long-term Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.

Secondary Skin Cancer in a Case with Long-term Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.

Journal: Internal medicine (Tokyo, Japan)

Published: January 13, 2022

Serial evaluation of the pharmacokinetics of ponatinib in patients with CML and Ph + ALL.

Serial evaluation of the pharmacokinetics of ponatinib in patients with CML and Ph + ALL.

Journal: International journal of hematology

Published: March 19, 2021

Uterine relapse of Philadelphia chromosome-negative acute lymphoblastic leukemia.

Uterine relapse of Philadelphia chromosome-negative acute lymphoblastic leukemia.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: September 28, 2020

Pharmacokinetics of anti-thymocyte globulin in a patient with severe aplastic anemia treated with allogeneic bone marrow transplantation from a matched unrelated donor.

Pharmacokinetics of anti-thymocyte globulin in a patient with severe aplastic anemia treated with allogeneic bone marrow transplantation from a matched unrelated donor.

Journal: Blood cell therapy

Published: August 04, 2020

Three cases of late-onset anthracycline-related cardiomyopathy due to chemotherapies for hematological malignancy.

Three cases of late-onset anthracycline-related cardiomyopathy due to chemotherapies for hematological malignancy.

Journal: Journal of echocardiography

Published: April 01, 2020

Clinical features and treatment outcomes of opportunistic infections among human T-lymphotrophic virus type 1 (HTLV-1) carriers and patients with adult T-cell leukemia-lymphoma (ATL) at a single institution from 2006 to 2016.

Clinical features and treatment outcomes of opportunistic infections among human T-lymphotrophic virus type 1 (HTLV-1) carriers and patients with adult T-cell leukemia-lymphoma (ATL) at a single institution from 2006 to 2016.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: December 24, 2019

Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018).

Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018).

Journal: Internal medicine (Tokyo, Japan)

Published: April 19, 2019

Reduced-intensity conditioning followed by cord blood transplantation in a patient with refractory folliculotropic mycosis fungoides.

Reduced-intensity conditioning followed by cord blood transplantation in a patient with refractory folliculotropic mycosis fungoides.

Journal: International journal of hematology

Published: April 22, 2013

Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma.

Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma.

Journal: International journal of hematology

Published: November 04, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026